These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2112039)

  • 1. Interstitial pneumonitis associated with ifosfamide therapy.
    Baker WJ; Fistel SJ; Jones RV; Weiss RB
    Cancer; 1990 May; 65(10):2217-21. PubMed ID: 2112039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Patsner B; Greenberg S
    Gynecol Oncol; 1995 Sep; 58(3):386-8. PubMed ID: 7672707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
    Elias A; Ryan L; Aisner J; Antman KH
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):41-9. PubMed ID: 2110385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.
    Ishiyama Y; Inakawa T; Yoshino M; Nishimura K; Horiuchi T; Ishihara H; Toki D; Kondo T
    Anticancer Res; 2024 Jul; 44(7):3213-3220. PubMed ID: 38925814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.
    Ogura K; Goto T; Imanishi J; Shinoda Y; Okuma T; Tsuda Y; Kobayashi H; Akiyama T; Hirata M; Yamamoto A; Kawano H
    Int J Clin Oncol; 2013 Feb; 18(1):170-6. PubMed ID: 22179493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
    Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
    J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH; Wen XP; Hu L
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.
    Bramwell V; Quirt I; Warr D; Verma S; Young V; Knowling M; Eisenhauer E
    J Natl Cancer Inst; 1989 Oct; 81(19):1496-9. PubMed ID: 2778839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
    Weh HJ; Zügel M; Wingberg D; Schwarz R; Zornig C; Dietel M; Hossfeld DK
    Onkologie; 1990 Dec; 13(6):448-52. PubMed ID: 2128712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
    Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
    J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has "MAID" made it in the management of high-risk soft-tissue sarcoma?
    O'Sullivan B; Bell RS
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):915-6. PubMed ID: 12829123
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of advanced sarcomas of bone and soft tissue.
    Antman KH
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
    Lee KW; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
    Jpn J Clin Oncol; 2011 Mar; 41(3):430-3. PubMed ID: 20926411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
    Le Cesne A; Antoine E; Spielmann M; Le Chevalier T; Brain E; Toussaint C; Janin N; Kayitalire L; Fontaine F; Genin J
    J Clin Oncol; 1995 Jul; 13(7):1600-8. PubMed ID: 7541449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dana-Farber Cancer Institute studies in advanced sarcoma.
    Antman KH; Elias A
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):7-15. PubMed ID: 2106162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide in soft tissue sarcoma.
    Zaidi SH; Iqbal Z; Mallick JA
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract]   [Full Text] [Related]  

  • 19. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD; Antman KH
    Cancer Treat Rep; 1986 Jul; 70(7):827-33. PubMed ID: 3087617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.